查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571734

肝病診斷市場規模、佔有率和趨勢分析報告：按診斷技術、疾病、最終用途、地區、細分市場預測，2024-2030

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnosis Technique, By Disease, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

肝病診斷市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球肝病診斷市場規模將達555.8億美元，2024年至2030年複合年成長率為6.61%。

市場參與企業增加資金籌措和研究舉措是預計推動市場成長的關鍵因素之一。例如，2019年11月，Glycotest, Inc.獲得上海復星醫藥股份有限公司（復星醫藥）第二筆300萬美元1000萬美元A輪資金籌措。透過這項投資， Glico將把其肝癌組合技術轉移給佛山醫藥，在中國進行商業化，並開發目前正在研發中的肝癌和肝纖維化測試。

公司正專注於合作研究和合作夥伴關係，以提高醫療保健質量，預計這將推動市場發展。例如，2019 年 10 月，Perspectum Diagnostics 建立夥伴關係，在新加坡 Precious 醫療中心提供 LiverMultiScan。此次合作的目的是提高人們的認知，將肝臟檢查作為健康檢查的一個組成部分。

支持開發能夠準確區分良性和惡性病變的新診斷方法的研究和開發預計將推動市場成長。例如，柏林 Charite-Universitatsmedizin 的研究人員使用斷層彈性成像技術來視覺化腫瘤的機械特性，並使用新的磁振造影來檢測腫瘤一致性分級 (MRI) 技術。

此外，該公司還進行臨床試驗以開發具有高靈敏度和特異性的新測試。例如，高級醫學研究所正在進行一項臨床試驗，對 1,600 名肝硬化患者進行超音波切片檢查以量化 cfDNA 甲基化與超音波檢查的比較。此次檢查預計2020年完成。

準確診斷的開發和商業化預計將推動市場發展。例如，2020 年 3 月，ENDRA Life Sciences Inc. 的 TAEUS FLIP 系統獲得了 CE 標誌。此系統測量肝臟脂肪，以識別和監測非酒精性脂肪肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH)。超音波系統。

肝病診斷市場報告亮點

  • 診斷成像領域佔據最大的收益佔有率，預計將以最快的複合年成長率成長。這是由於肝病診斷市場的主要企業採取了許多舉措來開發先進的診斷影像技術。
  • 2023年，醫院業務佔最大的銷售佔有率，約45.07%。這是因為大多數患者都使用配備齊全的診斷檢測設備的醫院。
  • 北美佔市場主導地位，2023 年收益佔有率最大，超過 41.71%，其次是歐洲。研發的高投資和主要參與者的存在預計將成為推動該地區肝病診斷市場成長的因素。
  • 預計亞太地區在預測期內將以最快的複合年成長率成長。老年人口的增加和對定期檢查的認知正在促進該地區肝病診斷市場的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球肝病診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
    • 市場機會分析
  • 全球肝病診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 全球肝病診斷市場：診斷技術預估及趨勢分析

  • 細分儀表板
  • 全球肝病診斷市場診斷技術波動分析
  • 2018-2030年全球肝病診斷市場規模及趨勢分析（依診斷技術）
  • 影像
  • 實驗室測試
  • 內視鏡檢查
  • 切片檢查
  • 其他

第5章全球肝病診斷市場：疾病估計與趨勢分析

  • 細分儀表板
  • 全球肝病診斷市場疾病波動分析
  • 2018-2030年全球肝病診斷市場規模及趨勢分析（依疾病）
  • NAFLD
  • NASH
  • 纖維化
  • 肝硬化
  • HCC
  • 其他

第6章 全球肝病診斷市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 全球肝病診斷市場的最終用途變化分析
  • 醫院
  • 研究所
  • 其他

第7章肝病診斷市場：區域估計與趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場佔有率分析
  • 主要身份驗證提供者/方案所有者列表
  • 公司簡介/上市公司
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Randox Laboratories Ltd
    • Boston Scientific Corporation
    • Laboratory Corporation of America Holdings
    • Fujifilm Corporation
    • Horiba Medical
    • Siemens Healthcare GmbH
    • Quest Diagnostics
Product Code: GVR-4-68038-693-6

Liver Disease Diagnostics Market Growth & Trends:

The global liver disease diagnostics market size is expected to reach USD 55.58 billion by 2030, expanding at a CAGR of 6.61% from 2024 to 2030, according to a new report by Grand View Research, Inc. increasing funding and research initiatives undertaken by market players is one of the major factors expected to propel market growth. For instance, in November 2019, Glycotest, Inc. received the second USD 3.0 million tranche of USD 10.0 million Series A funding from Shanghai Fosun Pharmaceutical Co., Ltd.(Fosun Pharma). Under this investment, Glycotest, Inc. transferred HCC panel technology to Fosun Pharma to commercialize in China and develop tests for liver cancer and liver fibrosis that are currently under pipeline.

Companies are focusing on collaborations and partnership to improve the quality of care,which is anticipated to drive the market. For instance, in October 2019, Perspectum Diagnostics entered into a partnership to offer LiverMultiScan at Precious Medical Center in Singapore. The aim of this partnership was to create awareness among people to consider liver checking as an integral part of their health screening.

Researchers conducting studies to support the development of novel diagnostic methods that can accurately differentiate between benign and malignant lesions are expected to fuel market growth. For instance, researchers from Charite - Universitatsmedizin Berlin used tomoelastography to visualize mechanical properties of tumors and developed a new Magnetic Resonance Imaging (MRI) technique to detect grading of tumor consistency.

Furthermore, companies are conducting clinical trials to develop new tests with high sensitivity and specificity. For instance, Laboratory for Advanced Medicine is conducting a clinical trial on 1,600 patients with liver cirrhosis using invasive biopsy through quantification of cfDNA methylation and comparing it with ultrasound technique. The test is projected to be completed in 2020.

Development and commercialization of accurate diagnostic methods is expected to boost the market. For instance, in March 2020, ENDRA Life Sciences Inc. received CE mark for TAEUS FLIP system. This system measures liver fat to identify and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). It is an ultrasound system that accurately and at point of care quantifies fat in the liver.

Liver Disease Diagnostics Market Report Highlights:

  • The imaging segment accounted for the largest revenue share and is expected to grow at the fastest CAGR. This is attributed to the rising number of initiatives taken by key players in the liver disease diagnostics market to develop advanced imaging techniques.
  • The hospitals segment held the largest revenue share of around 45.07% in 2023 as the majority of patients rely on hospitals well-equipped with diagnostic testing devices.
  • North America dominated the market and accounted for the largest revenue share of over 41.71% in 2023 followed by Europe. High investments in R&D and the presence of key players are some factors expected to be responsible for the growth of the market for liver disease diagnostics in the region.
  • Asia Pacific is expected to grow at the fastest CAGR during the forecast period. Increasing geriatric population and awareness about regular check-ups are contributing to the growth of the market for liver disease diagnostics in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Diagnosis Technique Segment
    • 1.2.2. Disease Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Liver Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of Liver Diseases
      • 3.2.1.2. Advancements in Diagnostic Technologies
      • 3.2.1.3. Increasing Awareness and Early Detection
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Advanced Diagnostics
      • 3.2.2.2. Limited Awareness in Developing Regions
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Liver Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Liver Disease Diagnostics Market: Diagnosis Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Liver Disease Diagnostics Market Diagnosis Technique Movement Analysis
  • 4.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Diagnosis Technique, 2018 to 2030 (USD Million)
  • 4.4. Imaging
    • 4.4.1. Imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Laboratory Tests
    • 4.5.1. Laboratory Tests market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Endoscopy
    • 4.6.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Biopsy
    • 4.7.1. Biopsy market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Liver Disease Diagnostics Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Liver Disease Diagnostics Market Disease Movement Analysis
  • 5.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
  • 5.4. NAFLD
    • 5.4.1. NAFLD market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. NASH
    • 5.5.1. NASH market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Fibrosis
    • 5.6.1. Fibrosis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cirrhosis
    • 5.7.1. Cirrhosis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. HCC
    • 5.8.1. HCC market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Liver Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Liver Disease Diagnostics Market End Use Movement Analysis
    • 6.2.1. Global Liver Disease Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Laboratories
    • 6.4.1. Laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. List of Key Certification Providers/Scheme Owners
  • 8.5. Company Profiles/Listing
    • 8.5.1. Abbott
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. F. Hoffmann-La Roche Ltd.
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Thermo Fisher Scientific Inc.
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Randox Laboratories Ltd
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Boston Scientific Corporation
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Laboratory Corporation of America Holdings
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Fujifilm Corporation
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Horiba Medical
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Siemens Healthcare GmbH
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Quest Diagnostics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviation
  • Table 3. U.S. Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 4. U.S. Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 5. U.S. Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America Liver Disease Diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 8. North America Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 9. North America Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 11. Canada Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 12. Canada Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Mexico Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 14. Mexico Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 15. Mexico Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe Liver Disease Diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 17. Europe Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 18. Europe Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 19. Europe Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20. UK Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 21. UK Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 22. UK Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 24. Germany Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 25. Germany Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26. France Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 27. France Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 28. France Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Italy Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 30. Italy Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 31. Italy Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 32. Spain Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 33. Spain Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 34. Spain Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Denmark Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 36. Denmark Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 37. Denmark Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Sweden Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 39. Sweden Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 40. Sweden Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Norway Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 42. Norway Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 43. Norway Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Asia Pacific Liver Disease Diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 45. Asia Pacific Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 46. Asia Pacific Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Japan Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 49. Japan Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 50. Japan Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 51. China Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 52. China Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 53. China Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54. India Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 55. India Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 56. India Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57. Australia Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 58. Australia Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 59. Australia Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60. South Korea Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 61. South Korea Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 62. South Korea Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 63. Thailand Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 64. Thailand Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 65. Thailand Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Latin America Liver Disease Diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 67. Latin America Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 68. Latin America Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 69. Latin America Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Brazil Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 71. Brazil Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 72. Brazil Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 73. Argentina Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 74. Argentina Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 75. Argentina Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 76. MEA Liver Disease Diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 77. MEA Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 78. MEA Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 79. MEA Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 80. South Africa Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 81. South Africa Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 82. South Africa Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 86. UAE Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 87. UAE Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 88. Kuwait Liver Disease Diagnostics market, by diagnosis technique, 2018 - 2030 (USD Million)
  • Table 89. Kuwait Liver Disease Diagnostics market, by disease, 2018 - 2030 (USD Million)
  • Table 90. Kuwait Liver Disease Diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Data triangulation techniques
  • Fig. 3. Primary research pattern
  • Fig. 4. Market research approaches
  • Fig. 5. Value-chain-based sizing & forecasting
  • Fig. 6. QFD modelling for market share assessment
  • Fig. 7. Market formulation & validation
  • Fig. 8. Liver disease diagnostics: Market outlook
  • Fig. 9. Liver disease diagnostics: Competitive insights
  • Fig. 10. Parent market outlook
  • Fig. 11. Related/ancillary market outlook
  • Fig. 12. Penetration and growth prospect mapping
  • Fig. 13. Industry value chain analysis
  • Fig. 14. Liver disease diagnostics market driver impact
  • Fig. 15. Liver disease diagnostics market restraint impact
  • Fig. 16. Liver disease diagnostics market strategic initiatives analysis
  • Fig. 17. Liver disease diagnostics market: disease movement analysis
  • Fig. 18. Liver disease diagnostics market: disease outlook and key takeaways
  • Fig. 19. NAFLD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20. NASH market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21. Fibrosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22. Cirrhosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23. HCC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25. Liver disease diagnostics market: Diagnosis technique movement analysis
  • Fig. 26. Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
  • Fig. 27. Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28. Laboratory tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29. Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30. Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32. Liver disease diagnostics market: End use movement analysis
  • Fig. 33. Liver disease diagnostics market: End use outlook and key takeaways
  • Fig. 34. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35. Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37. Global liver disease diagnostics market: Regional movement analysis
  • Fig. 38. Global liver disease diagnostics market: Regional outlook and key takeaways
  • Fig. 39. North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)